Literature DB >> 11462046

DNA-induced structural changes in the papillomavirus capsid.

C Fligge1, F Schäfer, H C Selinka, C Sapp, M Sapp.   

Abstract

Human papillomavirus capsid assembly requires intercapsomeric disulfide bonds between molecules of the major capsid protein L1. Virions isolated from naturally occurring lesions have a higher degree of cross-linking than virus-like particles (VLPs), which have been generated in eukaryotic expression systems. Here we show that DNA encapsidation into VLPs leads to increased cross-linking between L1 molecules comparable to that seen in virions. A higher trypsin resistance, indicating a tighter association of capsomeres through DNA interaction, accompanies this structural change.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462046      PMCID: PMC115009          DOI: 10.1128/JVI.75.16.7727-7731.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

Authors:  C Fligge; T Giroglou; R E Streeck; M Sapp
Journal:  Virology       Date:  2001-05-10       Impact factor: 3.616

2.  Human papillomavirus infection requires cell surface heparan sulfate.

Authors:  T Giroglou; L Florin; F Schäfer; R E Streeck; M Sapp
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Immunological analyses of human papillomavirus capsids.

Authors:  T Giroglou; M Sapp; C Lane; C Fligge; N D Christensen; R E Streeck; R C Rose
Journal:  Vaccine       Date:  2001-02-08       Impact factor: 3.641

4.  Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells.

Authors:  C Volpers; P Schirmacher; R E Streeck; M Sapp
Journal:  Virology       Date:  1994-05-01       Impact factor: 3.616

5.  Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6.

Authors:  K Kawana; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines.

Authors:  M Sapp; C Fligge; I Petzak; J R Harris; R E Streeck
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids.

Authors:  M E Hagensee; N H Olson; T S Baker; D A Galloway
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.

Authors:  R C Rose; R C Reichman; W Bonnez
Journal:  J Gen Virol       Date:  1994-08       Impact factor: 3.891

9.  Infectious human papillomavirus type 18 pseudovirions.

Authors:  Y Stauffer; K Raj; K Masternak; P Beard
Journal:  J Mol Biol       Date:  1998-10-30       Impact factor: 5.469

10.  In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.

Authors:  K Kawana; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  23 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Atomic model of the papillomavirus capsid.

Authors:  Yorgo Modis; Benes L Trus; Stephen C Harrison
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Maturation of papillomavirus capsids.

Authors:  Christopher B Buck; Cynthia D Thompson; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.

Authors:  Timothy D Culp; Christin M Spatz; Cynthia A Reed; Neil D Christensen
Journal:  Virology       Date:  2007-01-12       Impact factor: 3.616

Review 5.  The evolving field of human papillomavirus receptor research: a review of binding and entry.

Authors:  Adam B Raff; Andrew W Woodham; Laura M Raff; Joseph G Skeate; Lisa Yan; Diane M Da Silva; Mario Schelhaas; W Martin Kast
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 6.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

7.  Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.

Authors:  Miriam Becker; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

8.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

9.  Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.

Authors:  Valerie Laniosz; Kha C Nguyen; Patricio I Meneses
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry.

Authors:  Gilles Spoden; Lena Kühling; Nicole Cordes; Bettina Frenzel; Martin Sapp; Klaus Boller; Luise Florin; Mario Schelhaas
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.